Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer
SMRTR summary
University of Chicago researchers engineered a probiotic bacteria, Bifidobacterium longum, to deliver immune-stimulating treatment directly into pancreatic tumors. The bacteria naturally thrive in low-oxygen environments common in tumors, acting as tiny drug factories. Results improved significantly when combined with chemotherapy, radiation, or immunotherapy, though human trials are still needed.
SMRTR provides this summary for quick context. The original article belongs to Science Daily.
Read the original article